M&T Bank Corp 10x Genomics, Inc. Transaction History

M&T Bank Corp

$28.9 Billion
Q3 2025

A detailed history of M&T Bank Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 20,417 shares of TXG stock, worth $324,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,417

Previous 20,886 2.25%

Holding current value

$324,426

Previous $241,000 1.24%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$11.34 - $14.64 $5,318 - $6,866	-469 Reduced 2.25%	20,417 $238,000
Q2 2025 Aug 13, 2025	BUY	$7.14 - $11.73 $149,126 - $244,992	20,886 New	20,886 $241,000
Q3 2024 Nov 15, 2024	BUY	$15.71 - $23.49 $141,515 - $211,597	9,008 New	9,008 $203,000
Q4 2023 Feb 06, 2024	BUY	$34.32 - $57.55 $154,474 - $259,032	4,501 New	4,501 $251,000
Q2 2023 Aug 09, 2023	BUY	$50.96 - $58.72 $9,682 - $11,156	190 Added 5.18%	3,860 $215,000

Q1 2023 May 11, 2023	BUY	$35.33 - $55.79 $129,661 - $204,749	3,670 New	3,670 $204,000
Q2 2022 Aug 05, 2022	SELL	$36.95 - $82.41 $107,746 - $240,307	-2,916 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$55.7 - $145.79 $47,902 - $125,379	860 Added 41.83%	2,916 $222,000
Q4 2021 Feb 07, 2022	SELL	$135.05 - $182.59 $7,427 - $10,042	-55 Reduced 2.61%	2,056 $305,000
Q3 2021 Oct 28, 2021	BUY	$145.58 - $192.14 $1,601 - $2,113	11 Added 0.52%	2,111 $307,000
Q2 2021 Aug 13, 2021	BUY	$134.22 - $202.37 $38,521 - $58,080	287 Added 15.83%	2,100 $412,000
Q1 2021 May 06, 2021	BUY	$140.25 - $196.86 $14,586 - $20,473	104 Added 6.09%	1,813 $328,000
Q4 2020 Feb 12, 2021	BUY	$126.47 - $163.7 $216,137 - $279,763	1,709 New	1,709 $242,000

Others Institutions Holding TXG

# of Institutions

356

Shares Held

117M

Call Options Held

266K

Put Options Held

191K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.51B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account